ResearcherYonsei UniversityNo recent work listed

Kang-Yell Choi

ORCID-verified (high confidence)As of 9 November 2026

Matched on ORCID iD 0000-0002-0952-3276; OpenAlex author ID A5067941687.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Collaborators: 1

Papers, trials and grants by year

2021: 1 paper

Papers 1

Suppression of Wnt/β-catenin and RAS/ERK pathways provides a therapeutic strategy for gemcitabine-resistant pancreatic cancer. Last author DOI 10.1016/j.bbrc.2021.02.076 ↗

Closest collaborators

The 1 strongest of 1 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

Won-Ji Ryu · 1 shared paper, 2021
- Paper Suppression of Wnt/β-catenin and RAS/ERK pathways provides a therapeutic strategy for gemcitabine-resistant pancreatic … DOI 10.1016/j.bbrc.2021.02.076 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.